UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets

International journal of molecular sciences, 2020-10, Vol.21 (21), p.8081

2020

Volltextzugriff (PDF)

Counterpoint: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? No

Chest, 2024-03, Vol.165 (3), p.494-496

Sahay, Sandeep

2024

Volltextzugriff (PDF)

Rebuttal From Dr Sahay

Chest, 2024-03, Vol.165 (3), p.498-499

Sahay, Sandeep

2024

Volltextzugriff (PDF)

Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection

Pulmonary circulation, 2020-07, Vol.10 (3), p.1-5

2020

Volltextzugriff (PDF)

Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score

PloS one, 2020-11, Vol.15 (11), p.e0241504-e0241504

2020

Volltextzugriff (PDF)

G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?

Annals of hematology, 2021-03, Vol.100 (3), p.667-673

2021

Volltextzugriff (PDF)

Portopulmonary Hypertension: From Bench to Bedside

Frontiers in medicine, 2020-11, Vol.7, p.569413-569413

2020

Volltextzugriff (PDF)

Actinomycosis presenting as recurrent hepatic abscess

The American journal of medicine, 2017-01, Vol.130 (1), p.e21-e22

2017

Volltextzugriff (PDF)

TRANSITIONING FROM TYVASO TO LIQ861 IN PULMONARY ARTERIAL HYPERTENSION: A CASE STUDY

Chest, 2020-10, Vol.158 (4), p.A2166-A2166

Sahay, Sandeep

2020

Volltextzugriff (PDF)

Real-world experience using combination therapy with riociguat and risk assessment using REVEAL Lite 2.0 in patients with pulmonary arterial hypertension

Pulmonary circulation, 2020-01, Vol.10 (1), p.1-4

2020

Volltextzugriff (PDF)

Palliative care in pulmonary arterial hypertension: an underutilised treatment

European respiratory review, 2018-12, Vol.27 (150), p.180069

2018

Volltextzugriff (PDF)

Insulin‐like growth factor binding protein‐4: The quest for the breakthrough biomarker in pulmonary arterial hypertension

Pulmonary circulation, 2023-04, Vol.13 (2), p.e12252-n/a

2023

Volltextzugriff (PDF)

Evaluation and classification of pulmonary arterial hypertension

Journal of thoracic disease, 2019-09, Vol.11 (S14), p.S1789-S1799

Sahay, Sandeep

2019

Volltextzugriff (PDF)

Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study

Pulmonary circulation, 2020-10, Vol.10 (4), p.1-9

2020

Volltextzugriff (PDF)

An adult case of NOTCH3 mutation in pulmonary artery hypertension

Pulmonary circulation, 2022-01, Vol.12 (1), p.e12050-n/a

2022

Volltextzugriff (PDF)

Progression of pulmonary veno‐occlusive disease without pulmonary hypertension

Pulmonary circulation, 2022-01, Vol.12 (1), p.e12046-n/a

2022

Volltextzugriff (PDF)

Impact of human behavior on inspiratory flow profiles in patients with pulmonary arterial hypertension using AOS™ dry powder inhaler device

Pulmonary circulation, 2021-01, Vol.11 (1), p.1-9

2021

Volltextzugriff (PDF)

Management of pulmonary hypertension associated with valvular heart disease with angiotensin‐receptor neprilysin inhibitor

Pulmonary circulation, 2023-10, Vol.13 (4), p.n/a

2023

Volltextzugriff (PDF)

Pericardial effusion in pulmonary arterial hypertension

Pulmonary Circulation, 2013-09, Vol.3 (3), p.467-477

2013

Volltextzugriff (PDF)

Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies

Pulmonary circulation, 2020-10, Vol.10 (4), p.1-10

2020

Volltextzugriff (PDF)

Baffling Tachycardia

The American journal of medicine, 2015-11, Vol.128 (11), p.e19-e20

2015

Volltextzugriff (PDF)

Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data

ERJ open research, 2020-04, Vol.6 (2), p.199

2020

Volltextzugriff (PDF)

Pulmonary Hypertension Care Center Network

Chest, 2017-04, Vol.151 (4), p.749-754

2017

Volltextzugriff (PDF)

Evaluation and management of pulmonary arterial hypertension

Respiratory medicine, 2020-09, Vol.171, p.106099-106099, Article 106099

2020

Volltextzugriff (PDF)

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?

Pulmonary circulation, 2021-04, Vol.11 (2), p.1-3

2021

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(140)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets

Counterpoint: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? No

Rebuttal From Dr Sahay

Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection

Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score

G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?

Portopulmonary Hypertension: From Bench to Bedside

Actinomycosis presenting as recurrent hepatic abscess

TRANSITIONING FROM TYVASO TO LIQ861 IN PULMONARY ARTERIAL HYPERTENSION: A CASE STUDY

Real-world experience using combination therapy with riociguat and risk assessment using REVEAL Lite 2.0 in patients with pulmonary arterial hypertension

Palliative care in pulmonary arterial hypertension: an underutilised treatment

Insulin‐like growth factor binding protein‐4: The quest for the breakthrough biomarker in pulmonary arterial hypertension

Evaluation and classification of pulmonary arterial hypertension

Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study

An adult case of NOTCH3 mutation in pulmonary artery hypertension

Progression of pulmonary veno‐occlusive disease without pulmonary hypertension

Impact of human behavior on inspiratory flow profiles in patients with pulmonary arterial hypertension using AOS™ dry powder inhaler device

Management of pulmonary hypertension associated with valvular heart disease with angiotensin‐receptor neprilysin inhibitor

Pericardial effusion in pulmonary arterial hypertension

Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies

Baffling Tachycardia

Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data

Pulmonary Hypertension Care Center Network

Evaluation and management of pulmonary arterial hypertension

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?

Suchergebnisse filtern